RO 7239958
Alternative Names: RG-6217; RO-7239958Latest Information Update: 28 Jan 2022
Price :
$50 *
At a glance
- Originator Roche
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for phase-I development in Hepatitis-B in Bulgaria (SC, Injection)
- 28 Jan 2022 No recent reports of development identified for phase-I development in Hepatitis-B in China (SC, Injection)
- 28 Jan 2022 No recent reports of development identified for phase-I development in Hepatitis-B in Hong Kong (SC, Injection)